Latest Parkman Healthcare Partners LLC Stock Portfolio
Parkman Healthcare Partners LLC Performance:
2024 Q3: 8.78%YTD: 16.92%2023: 6.09%
Performance for 2024 Q3 is 8.78%, and YTD is 16.92%, and 2023 is 6.09%.
About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings
Parkman Healthcare Partners LLC is a hedge fund based in STAMFORD, CT. On 27-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $591.9 Millions. In it's latest 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $783.4 Millions as of 30 Sep, 2024.
The top stock holdings of Parkman Healthcare Partners LLC are BSX, PODD, LLY. The fund has invested 4.8% of it's portfolio in BOSTON SCIENTIFIC CORP and 4.7% of portfolio in INSULET CORP.
The fund managers got completely rid off ELEVANCE HEALTH INC (ELV), HUMANA INC (HUM) and CENCORA INC (ABC) stocks. They significantly reduced their stock positions in INARI MED INC (NARI), ARCELLX INC (ACLX) and INSMED INC (INSM). Parkman Healthcare Partners LLC opened new stock positions in TELEFLEX INCORPORATED (TFX), STRYKER CORPORATION (SYK) and VIRIDIAN THERAPEUTICS INC (VRDN). The fund showed a lot of confidence in some stocks as they added substantially to ARCUS BIOSCIENCES INC (RCUS), KEROS THERAPEUTICS INC (KROS) and THIRD HARMONIC BIO INC (THRD).
The top stock holdings of Parkman Healthcare Partners LLC are BSX, PODD, LLY. The fund has invested 4.8% of it's portfolio in BOSTON SCIENTIFIC CORP and 4.7% of portfolio in INSULET CORP.
The fund managers got completely rid off ELEVANCE HEALTH INC (ELV), HUMANA INC (HUM) and CENCORA INC (ABC) stocks. They significantly reduced their stock positions in INARI MED INC (NARI), ARCELLX INC (ACLX) and INSMED INC (INSM). Parkman Healthcare Partners LLC opened new stock positions in TELEFLEX INCORPORATED (TFX), STRYKER CORPORATION (SYK) and VIRIDIAN THERAPEUTICS INC (VRDN). The fund showed a lot of confidence in some stocks as they added substantially to ARCUS BIOSCIENCES INC (RCUS), KEROS THERAPEUTICS INC (KROS) and THIRD HARMONIC BIO INC (THRD).
Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Parkman Healthcare Partners LLC made a return of 8.78% in the last quarter. In trailing 12 months, it's portfolio return was 33.01%.
New Buys
| Ticker | $ Bought |
|---|---|
| teleflex incorporated | 23,778,300 |
| stryker corporation | 10,115,300 |
| viridian therapeutics inc | 9,668,750 |
| quest diagnostics inc | 8,538,750 |
| jazz pharmaceuticals plc | 8,050,040 |
| ptc therapeutics inc | 7,234,500 |
| alnylam pharmaceuticals inc | 7,009,140 |
| axogen inc | 5,788,690 |
New stocks bought by Parkman Healthcare Partners LLC
Additions
| Ticker | % Inc. |
|---|---|
| arcus biosciences inc | 146 |
| keros therapeutics inc | 112 |
| third harmonic bio inc | 78.38 |
| silence therapeutics plc | 71.77 |
| cvrx inc | 52.56 |
| replimune group inc | 45.48 |
| terns pharmaceuticals inc | 39.84 |
| essa pharma inc | 37.22 |
Additions to existing portfolio by Parkman Healthcare Partners LLC
Reductions
| Ticker | % Reduced |
|---|---|
| inari med inc | -77.35 |
| arcellx inc | -57.61 |
| insmed inc | -55.86 |
| dexcom inc | -55.00 |
| alphatec hldgs inc | -53.5 |
| ironwood pharmaceuticals inc | -48.02 |
| anaptysbio inc | -46.12 |
| nuvalent inc | -45.44 |
Parkman Healthcare Partners LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| ventyx biosciences inc | -2,679,650 |
| augmedix inc | -498,824 |
| bristol-myers squibb co | -8,306,000 |
| quanterix corp | -2,329,940 |
| ionis pharmaceuticals inc | -7,706,860 |
| fortrea hldgs inc | -3,565,630 |
| tela bio inc | -459,735 |
| haemonetics corp mass | -6,294,020 |
Parkman Healthcare Partners LLC got rid off the above stocks
Sector Distribution
Parkman Healthcare Partners LLC has about 92.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 92.7 |
| Others | 6.7 |
Market Cap. Distribution
Parkman Healthcare Partners LLC has about 38% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 33.4 |
| SMALL-CAP | 33.3 |
| MID-CAP | 18.1 |
| UNALLOCATED | 6.9 |
| MEGA-CAP | 4.6 |
| MICRO-CAP | 3.5 |
Stocks belong to which Index?
About 74.5% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 45.2 |
| S&P 500 | 29.3 |
| Others | 25.5 |
Parkman Healthcare Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC has 93 stocks in it's portfolio. About 34.7% of the portfolio is in top 10 stocks. DXCM proved to be the most loss making stock for the portfolio. COO was the most profitable stock for Parkman Healthcare Partners LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABC | cencora inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABT | abbott labs | 1.80 | 123,601 | 14,091,800 | added | 1.38 | ||
| ACLX | arcellx inc | 0.71 | 66,492 | 5,552,750 | reduced | -57.61 | ||
| AGIO | agios pharmaceuticals inc | 1.62 | 285,099 | 12,666,900 | reduced | -36.14 | ||
| AKYA | akoya biosciences inc | 0.13 | 376,131 | 1,023,080 | added | 0.16 | ||
| ALNY | alnylam pharmaceuticals inc | 0.90 | 25,485 | 7,009,140 | new | |||
| ANAB | anaptysbio inc | 0.59 | 138,100 | 4,626,350 | reduced | -46.12 | ||
| ANNX | annexon inc | 0.25 | 328,613 | 1,945,390 | added | 0.54 | ||
| APLT | applied therapeutics inc | 0.98 | 907,294 | 7,712,000 | reduced | -20.99 | ||
| ARDX | ardelyx inc | 0.11 | 126,940 | 874,617 | reduced | -15.48 | ||
| ARVN | arvinas inc | 0.30 | 96,183 | 2,368,990 | reduced | -23.15 | ||
| ATEC | alphatec hldgs inc | 0.28 | 396,336 | 2,203,630 | reduced | -53.5 | ||
| AUGX | augmedix inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXGN | axogen inc | 0.74 | 412,888 | 5,788,690 | new | |||
| BCRX | biocryst pharmaceuticals inc | 0.45 | 464,048 | 3,526,760 | added | 15.88 | ||
| BCYC | bicycle therapeutics plc | 1.29 | 445,396 | 10,079,300 | reduced | -16.76 | ||
| BDX | becton dickinson & co | 1.85 | 60,011 | 14,468,700 | reduced | -11.96 | ||
| BMY | bristol-myers squibb co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BSX | boston scientific corp | 4.78 | 447,196 | 37,475,000 | reduced | -18.93 | ||
| CDMO | avid bioservices inc | 1.05 | 719,965 | 8,193,200 | added | 15.92 | ||